- Conditions: Anterior Cruciate Ligament Reconstruction; Regional Anesthesia, Saphenous Nerve Block
Interventions: Drug: Bupivacaine Only; Drug: Bupivacaine with 2 ml of Dexamethasone; Drug: Bupivacaine with 4 mg of Dexamethasone
Sponsors: Hospital for Special Surgery, New York; Hospital for Special Surgery, New York
Not yet recruiting - verified April 2012 - Condition: Stress Urinary Incontinence
Interventions: Drug: Bupivicaine + epinephrine; Drug: Sodium chloride + epinephrine
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified April 2012 - Condition: Pain
Interventions: Drug: fentanyl; Drug: fentanyl, sufentanil
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc
Recruiting - verified April 2012 - Condition: Breast Augmentation
Interventions: Drug: Morphine Sulfate; Drug: morphine sulfate, hydromorphone HCl
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc
Recruiting - verified May 2012 - Condition: Laparoscopic Appendectomy
Interventions: Drug: Ropivacaine; Drug: Bupivacaine
Sponsors: Nationwide Children's Hospital; Nationwide Children's Hospital
Not yet recruiting - verified April 2012 - Condition: HIV Infections
Interventions: Biological: HIV-MAG vaccine; Biological: IL-12 pDNA adjuvant; Biological: VSV HIV gag vaccine; Biological: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified May 2012 - Conditions: Prostate Cancer; Robotic Prostatectomy; Foley Catheter Discomfort
Interventions: Drug: Bupivacaine; Drug: Saline
Sponsors: Columbia University; Columbia University
Recruiting - verified March 2012 - Condition: Shoulder Pain
Interventions: Procedure: Superficial Cervical Plexus Block; Drug: Bupivacaine
Sponsors: University of Washington; University of Washington
Not yet recruiting - verified March 2012 - Condition: Postoperative Pain.
Interventions: Drug: Subpleural pain catheter with infusion of 0.125% bupivacaine; Drug: Standard acute pain management
Sponsors: Inova Health Care Services; Inova Health Care Services
Not yet recruiting - verified February 2012 - Conditions: Shoulder Pain; Injury of Shoulder Region; Disorder of Shoulder; Disorder of Rotator Cuff; Disorder of Tendon of Biceps
Interventions: Drug: Dexamethasone; Drug: Bupivacaine
Sponsors: Lifespan; Lifespan; Tufts Medical Center; United States Naval Medical Center, Portsmouth
Not yet recruiting - verified March 2012 - Conditions: Postoperative Pain; Paracervical Block; Laparoscopic Gynecologic Surgery
Interventions: Drug: Bupivacaine with epinephrine; Drug: Normal Saline
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine
Recruiting - verified February 2012 - Condition: Postoperative Pain
Intervention: Drug: Bupivicaine Infusion
Sponsors: Chang, Steve S., M.D.; Chang, Steve S., M.D.
Recruiting - verified February 2012 - Condition: Onset and Duration of a Digital Nerve Block With 2 Local Anesthesthetics.
Interventions: Drug: Lidocaine; Drug: Bupivacaine
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified February 2012 - Condition: Difference Between Femoral Nerve Block and Saphenous Block
Interventions: Procedure: Study Technique; Procedure: Control Technique
Sponsors: Hospital for Special Surgery, New York; Hospital for Special Surgery, New York
Not yet recruiting - verified March 2012 - Conditions: Neonatal Neurobehavior; Breastfeeding Outcomes
Interventions: Drug: Bolus 10mL 0.25% bupivacaine/ep 1:600,000; infusion 10mL/hour 0.25% bupivacaine and epi 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine/ epinephrine 1:600,000;infusion 10mL/hour 0.25% bupivacaine, 2 mcg/mL fentanyl, and epinephrine 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine, 10mcg/mL fentanyl, and epi 1:600,000; infusion 10mL/hour 0.25% bupivacaine, 2.5 mcg/mL fentanyl, and epi 1:800,000; Drug: Bolus 10mL 0.25% bupivacaine, 5 mcg/mL fentanyl, and epi 1:600,000; infusion 10mL/hour 0.25% bupivacaine, 3.5 mcg/mL fentanyl, and epi 1:800,000; Drug: No epidural fentanyl or bupivacaine
Sponsors: University Hospital Case Medical Center; University Hospital Case Medical Center
Not yet recruiting - verified April 2012 - Condition: Pain
Interventions: Drug: Bupivacaine; Drug: Saline
Sponsors: Johns Hopkins University; Johns Hopkins University
Not yet recruiting - verified December 2011 - Condition: Burns
Interventions: Procedure: Regional nerve block; Procedure: Catheter
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified December 2011 - Condition: Cleft Palate
Interventions: Drug: Oral acetaminophen; Drug: Ofirmev®; Drug: Opioid only
Sponsors: Loma Linda University; Loma Linda University
Recruiting - verified December 2011 - Conditions: Maternal Anaesthesia and Analgesia Affecting Fetus or Newborn; Breast Feeding; Fentanyl; Bupivacaine; Nalbuphine
Intervention:
Sponsors: University Hospital Case Medical Center; University Hospital Case Medical Center
Recruiting - verified February 2012 - Condition: Post Operative Pain
Interventions: Drug: Group A-Paravertebral block; Other: Group B- No block
Sponsors: Loyola University; Loyola University
Recruiting - verified November 2011 - Condition: Retraction of Colostomy
Interventions: Drug: Morphine Sulfate; Drug: bupivacaine liposome extended-release injectable suspension
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc; Registrat-Mapi
Recruiting - verified February 2012 - Condition: Retraction of Colostomy
Interventions: Drug: IV morphine sulfate; Drug: SKY0402 (bupivacaine liposome injectable suspension)
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc; Registrat-Mapi
Recruiting - verified February 2012 - Condition: Bowel Obstruction
Interventions: Drug: IV Morphine Sulfate; Drug: SKY0402 (bupivacaine liposome injectable suspension)
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc; Registrat-Mapi
Recruiting - verified April 2012 - Condition: Bowel Obstruction
Interventions: Drug: IV morphine sulfate; Drug: EXPAREL (bupivacaine liposome injectable suspension)
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc; Registrat-Mapi
Recruiting - verified February 2012 - Condition: BOWEL OBSTRUCTION
Interventions: Drug: Morphine Sulfate; Drug: bupivacaine liposome extended-release injectable suspension
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc; Registrat-Mapi
Recruiting - verified April 2012 - Condition: Bowel Obstruction
Interventions: Drug: Morphine Sulfate; Drug: bupivacaine liposome injectable suspension
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc; Registrat-Mapi
Recruiting - verified April 2012 - Condition: Bowel Obstruction
Interventions: Drug: morphine sulfate; Drug: bupivacaine liposome extended-release injectable suspension
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc; Registrat-Mapi
Recruiting - verified January 2012 - Condition: Bowel Obstruction
Interventions: Drug: IV Morphine Sulfate; Drug: SKY0402 (bupivacaine liposome extended-release injectable suspension)
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc; Registrat-Mapi
Recruiting - verified January 2012 - Condition: Bowel Obstruction
Interventions: Drug: IV morphine sulfate; Drug: SKY0402 (bupivacaine liposome extended-release injectable suspension)
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc; Registrat-Mapi
Recruiting - verified January 2012 - Condition: Bowel Obstruction
Interventions: Drug: IV morphine sulfate; Drug: SKY0402 (bupivacaine liposome injectable suspension)
Sponsors: Pacira Pharmaceuticals, Inc; Pacira Pharmaceuticals, Inc; Registrat-Mapi
Recruiting - verified January 2012 - Condition: Post Operative Pain
Interventions: Drug: 0.25% bupivicaine will be injected at the study port site; Drug: Saline will be injected at the study port site
Sponsors: Stony Brook University; Stony Brook University
Not yet recruiting - verified October 2011 - Conditions: Gynecologic Cancer; Post-operative Pain
Interventions: Drug: Bupivicaine; Drug: Placebo
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified September 2011 - Conditions: Rib Fractures; Analgesia, Epidural
Interventions: Procedure: ON-Q® Pain Relief System; Procedure: Thoracic epidural catheter
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; I-Flow Corporation - A Division of Kimberly Clark Healthcare
Not yet recruiting - verified July 2011 - Conditions: Sacroiliac Joint Pain; Sympathetically Maintained Pain
Interventions: Procedure: sacroiliac joint injection; Procedure: Sympathetic block; Drug: bupivacaine; Drug: corticosteroid
Sponsors: Johns Hopkins University; Johns Hopkins University
Recruiting - verified April 2011 - Condition: Post-operative Pain
Interventions: Drug: Bupivacaine / Lidocaine; Drug: Lidocaine
Sponsors: Baylor Research Institute; Baylor Research Institute
Recruiting - verified February 2012 - Condition: Prostate CA
Interventions: Drug: Dexamethasone; Procedure: TAP block
Sponsors: Steward St. Elizabeth's Medical Center of Boston, Inc.; Steward St. Elizabeth's Medical Center of Boston, Inc.
Recruiting - verified February 2011 - Condition: The Duration of Motor Block for Sciatic Block Following TKR May Vary Between 12-36 Hrs Depending on the Amount of Local Anesthetic Given.
Interventions: Drug: Bupivacaine; Drug: Ropivacaine
Sponsors: Northwestern University; Northwestern University
Recruiting - verified March 2012 - Conditions: Pain; Cancer
Intervention: Procedure: EUS-guided Celiac Plexus Neurolysis
Sponsors: Northwestern University; Northwestern University
Recruiting - verified July 2011 - Conditions: Pain; Breastfeeding
Intervention:
Sponsors: Northwestern University; Northwestern University
Recruiting - verified January 2012 - Condition: Migraine Headache
Interventions: Drug: bupivicaine/methylprednisolone (Active Injection); Drug: Placebo Injection
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified November 2011 - Condition: Inguinal Hernia
Interventions: Drug: Regional Anesthesia; Drug: General Anesthesia
Sponsors: Children's Hospital Boston; Children's Hospital Boston; Royal Children's Hospital; Royal Hospital for Sick Children; Murdoch Childrens Research Institute; Food and Drug Administration (FDA)
Recruiting - verified August 2011 - Conditions: Pain; Hip Fractures
Intervention: Procedure: Femoral Nerve Block
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine; National Institute on Aging (NIA)
Recruiting - verified February 2012 - Condition: Colon Cancer
Interventions: Procedure: Regional anesthesia and analgesia; Drug: general anesthesia followed by opioid analgesia
Sponsors: Outcomes Research Consortium; Outcomes Research Consortium
Recruiting - verified May 2012
 |
Bupivacaine Clinical Trials |
